Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enrichment for the POLE mutated against p53 wild subtype using clinicopathologic factors and cyclin B1 immunohistochemistry in endometrial cancer.

Journal of gynecologic oncology - 1 May 2024

Parulekar Maitreyee, Kim Hyojin, Kim Kidong, Ala Aiob

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cyclin B1
Share to DNA Polymerase II
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Mutation

Share to Poly-ADP-Ribose Binding Proteins

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 38764327
DOI: 10.3802/jgo.2024.35.e94
PMCID: PMC11107285

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enrichment for the POLE mutated against p53 wild subtype using clinicopathologic factors and cyclin B1 immunohistochemistry in endometrial cancer.PMID 38764327Read ↗

The Clinical and Pathological Characteristics of POLE-Mutated Endometrial Cancer: A Comprehensive ReviewSemantic proximity Read ↗

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial.Semantic proximity Read ↗

The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients.Semantic proximity Read ↗

Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review.Semantic proximity Read ↗

Endometrial cancer with a POLE mutation progresses frequently through the type I pathway despite its high-grade endometrioid morphology: a cohort study at a single institution in Japan.Semantic proximity Read ↗

"Surface epithelial slackening" pattern in endometrioid carcinoma: A morphological feature for differentiating the POLE mutation-subtype from the no specific molecular profile subtype.Semantic proximity Read ↗

Cervical Cytology Preserves Histologically Detected Surface Epithelial Slackening, Unique to the POLE Mutation-subtype in Endometrial Cancer.Semantic proximity Read ↗

[Endometrial adenocarcinoma with mutations in POLE, TP53 genes and microsatellite instability].Semantic proximity Read ↗

TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.Semantic proximity Read ↗

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.Semantic proximity Read ↗

[Feasibility of identifying POLE-mutated endometrial carcinoma through a pathological features-based scoring system].Semantic proximity Read ↗

Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.